Study on the Medical Education Capability of the EyeTeacher Artificial Intelligence Platform
Launched by TSINGHUA UNIVERSITY · Dec 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new educational tool called the EyeTeacher, which uses artificial intelligence (AI) to help medical students learn about ophthalmology, the branch of medicine that deals with the eyes. The goal is to see if this AI platform can provide better learning experiences compared to traditional teaching methods, especially for students who haven’t yet studied ophthalmology. By using EyeTeacher, we hope to make high-quality medical education more accessible, regardless of where students are located or their language background.
To participate in this study, candidates must be clinical medical students aged 21 to 40 who have not taken any ophthalmology courses before. Participants will be asked to sign a consent form and complete a questionnaire. The trial will assess how well the EyeTeacher helps improve their knowledge and skills and will compare the results to those from traditional teaching. This is an exciting opportunity for students to engage with cutting-edge technology in their education!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical medical students who have not taken ophthalmology courses
- • Age 21-40
- • Gender not restricted
- • Sign the informed consent form
- Exclusion Criteria:
- • Refusal of the research protocol.
- • Participants unwilling or unable to understand and complete the questionnaire.
About Tsinghua University
Tsinghua University, a prestigious research institution located in Beijing, China, is dedicated to advancing scientific knowledge and innovation in various fields, including medicine and healthcare. As a clinical trial sponsor, Tsinghua University leverages its extensive academic resources and interdisciplinary expertise to conduct rigorous research aimed at improving patient outcomes and advancing medical science. The university fosters collaboration among researchers, healthcare professionals, and industry partners to ensure the successful design and execution of clinical trials, ultimately contributing to the development of novel therapies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melbourne, Victoria, Australia
Beijing, Beijing, China
London, , United Kingdom
Kuala Lumpur, , Malaysia
Singapore, , Singapore
Beijing, Beijing, China
Accra, Greater Accra Region, Ghana
Chennai, Tamil Nadu, India
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported